InsiderClue
← All stocks

RIGEL PHARMACEUTICALS INC

RIGL Scheduled selling only
CIK 0001034842 #2685 in the set updated 20 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$305.87K
$160.43K on a plan · $145.44K straight out of an exercise
Sold at will
$0.00
0 of 3 sales
Net
−$305.87K
$0.00 against sales at will

By person

12 insiders · 14 transactions
12.1×

Raul R. Rodriguez holds 12.1 times base salary in stock. $9.57M of shares against $787.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Raul R. Rodriguez last reported holding, valued at $35.00, the price Common Stock was last bought or sold at on the open market here, on 22 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ali-Jackson Kamil
Director
—
$160.43K (2) scheduled
−$160.43K
10,125
0.0542%
$354.38K
+47.3%
MOOS WALTER H
Director
—
$145.44K (1) scheduled
−$145.44K
18,472
0.0989%
$646.52K
+80.7%
RODRIGUEZ RAUL R
CEO, President
—
—
—
273,362
1.46%
$9.57M
+35.4%
Schorno Dean L
EVP & Chief Financial Officer
—
—
—
82,962
0.4441%
$2.90M
+93.9%
Santos David A
EVP, Chief Commercial Officer
—
—
—
61,622
0.3299%
$2.16M
+64.7%
Furey Raymond J.
EVP, GC, CCO & Corp Sec
—
—
—
50,559
0.2707%
$1.77M
+116.1%
HANNAH ALISON L.
EVP, Chief Medical Officer
—
—
—
35,025
0.1875%
$1.23M
+1,375%
Rojkjaer Lisa
EVP, Chief Medical Officer
—
—
—
34,003
0.1820%
$1.19M
—
Wasman Jane
Director
—
—
—
18,250
0.0977%
$638.75K
+82.5%
LAPOINTE ANTHONY GREGG
Director
—
—
—
18,250
0.0977%
$638.75K
+82.5%
Frohlich Mark W
Director
—
—
—
7,000
0.0375%
$245.00K
—
MILLER MICHAEL PATRICK
Director
—
—
—
5,937
0.0318%
$207.80K
+3,075%

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Schorno Dean L
2 Sep 2026
EVP & Chief Financial Officer
Exercised, kept
1,286
$24.20
$31.12K
Schorno Dean L
2 Sep 2026
EVP & Chief Financial Officer
Exercised, kept
2,000
$24.20
$48.40K
Schorno Dean L
2 Sep 2026
EVP & Chief Financial Officer
Exercised, kept
620
$18.70
$11.59K
Schorno Dean L
2 Sep 2026
EVP & Chief Financial Officer
Exercised, kept
694
$12.70
$8.81K
Ali-Jackson Kamil
22 Jun 2026
Director
Sold on a plan
2,500
$35.00
$87.50K
Schorno Dean L
1 Jun 2026
EVP & Chief Financial Officer
Exercised, kept
2,181
$12.70
$27.70K
Schorno Dean L
1 Jun 2026
EVP & Chief Financial Officer
Exercised, kept
1,200
$18.70
$22.44K
Ali-Jackson Kamil
26 May 2026
Director
Sold on a plan
2,500
$29.17
$72.93K
MOOS WALTER H
20 Feb 2026
Director
Sold after exercise
4,000
$36.36
$145.44K
RODRIGUEZ RAUL R
26 Jan 2026
CEO, President
Exercised, kept
40,000
$27.40
$1.10M
RODRIGUEZ RAUL R
26 Jan 2026
CEO, President
Exercised, kept
40,000
$27.40
$1.10M
Schorno Dean L
22 Dec 2025
EVP & Chief Financial Officer
Exercised, kept
1,667
$18.70
$31.17K
Schorno Dean L
22 Dec 2025
EVP & Chief Financial Officer
Exercised, kept
2,846
$24.20
$68.87K
Schorno Dean L
22 Dec 2025
EVP & Chief Financial Officer
Exercised, kept
1,987
$20.00
$39.74K

What was left out

Form 4 filings counted 41
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 428,481
History held since 1 Sep 2016